Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis
Author(s): Lin Daniel W, Coleman Ilsa M, Hawley Sarah, Dumpit Ruth, Gifford David, Kezele Philip, Hung Hau, Knudsen Beatrice S, Kristal Alan R, Nelson Peter S
Publication: Journal of Clinical Oncology, 2006, Vol. 24, Page 3763
PubMed ID: 16822846 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to determine if gene expression, as measured by cDNA microarray, is altered following surgical resection. Biospies were collected in situ from the prostate prior to vascular clamp placement or ex vivo after radical prostatectomy in twelve patients.
Summary of Findings:
Of the 5,753 cDNAs examined by cDNA microarray, 88 cDNAs representing 62 genes were altered in biopsies obtained from surgically resected specimens compared to biopsies procured in situ prior to vascular clamp placement. The false-discovery rate was estimated to be approximately 10%. Affected genes included several that are involved in acute phase response, IER2 and JUNB, cell proliferation regulation, P21Cip1 and KLF6, as well as those associated with the JNK stress-response pathway. No transcripts exhibiting a significant reduction in expression following surgical resection were observed.
Biospecimens
Preservative Types
- OCT
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform RNA DNA microarray Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Biospecimen Acquisition Method of tissue acquisition Biopsy
Surgical resection
-
Study Purpose
The purpose of this study was to determine if expression of a subset of genes identified by microarray (of DUSP1, KLF6, and AMACR) in fact differ among case-matched biopsy specimens procured in situ before vascular clamp placement or ex vivo after radical prostatectomy. A total of 8 cores were obtained from each of the 12 patients assessed.
Summary of Findings:
Quantitative RT-PCR (qRT-PCR) analysis revealed that DUSP1 and KLF6 expression were significantly upregulated, by 14- and 4-fold respectively, in biopsy specimens procured after surgical resection compared to those collected before vascular clamp placement. AMACAR expression did not differ significantly among biopsy specimens collected pre-and post-resection. QRT-PCR results are consistent with those reported for microarray.
Biospecimens
Preservative Types
- OCT
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform RNA Real-time qRT-PCR Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Real-time qRT-PCR Specific Targeted nucleic acid DUSP1
KLF6
AMACR
Biospecimen Acquisition Method of tissue acquisition Biopsy
Surgical resection
-
Study Purpose
The purpose of this study was to examine the potential influence of patient-related variables (including patient age, prostate gland volume, prostate-specific antigen concentration), and surgery-related factors (including warm ischemia time, estimated blood loss amount, and surgical duration) on gene expression as measured by microarray. Microarray analysis was limited to a subset of 62 genes that displayed differential expression as a result of time of procurement, pre- versus post-surgical resection. Four core biopsies were obtained from each of the 12 patients assessed before vascular clamp placement and again after completion of a radical prostatectomy.
Summary of Findings:
Statistically relevant correlations between clinical and operative variables and gene expression were limited to prostate gland volume. The magnitude of change induced by surgical resection when compared to biopsies taken in situ was negatively correlated to prostate gland volume for 55 (or 89%) of the 62 genes examined, translating to smaller differences in transcript expression for larger prostate gland volumes. Conversely, age, PSA concentration, total operative time, warm ischemia time, and estimated blood loss were not associated with differences in gene expression, although statistical power was modest.
Biospecimens
Preservative Types
- OCT
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform RNA DNA microarray Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Preaquisition Blood loss amount 450 ml
600 ml
650 ml
700 ml
800 ml
950 ml
1000 ml
1100 ml
1500 ml
1600 ml
2100 ml
Preaquisition Warm ischemia time 19 min
20 min
25 min
26 min
27 min
29 min
30 min
33 min
35 min
36 min
40 min
Preaquisition Patient age 53
59
60
62
64
65
67
68
69
Preaquisition Biomarker level 2.5 ng/dL
3.5 ng/dL
4.2 ng/dL
4.6 ng/dL
4.7 ng/dL
5.0 ng/dL
5.4 ng/dL
5.6 ng/dL
6.3 ng/dL
8.2 ng/dL
16.0 ng/dL
Preaquisition Surgery duration 164 min
176 min
180 min
185 min
187 min
196 min
201 min
203 min
210 min
221 min
237 min
Biospecimen Acquisition Organ measurements Prostate gland volume (31 ml)
35 ml
36 ml
37 ml
39 ml
43 ml
49 ml
50 ml
65 ml
78 ml
149 ml